Valuation Scholar Rock Holding Corporation

Stocks

Market Closed - Nasdaq 07:00:00 17/10/26 am AEDT			5-day change	1st Jan Change
39.90 ^USD	-1.82%		-5.43%	-9.42%

09/10	Scholar Rock Resubmits Apitegromab Application in EU for Spinal Muscular Atrophy	MT
08/10	Scholar Rock Resubmits Apitegromab Marketing Authorisation Application To European Medicines Agency For Treatment Of Children And Adults With Spinal Muscular Atrophy	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	872.1	467.6	1,356	4,046	4,493	4,862	-	-
Change	-	-46.39%	190.08%	198.32%	11.06%	8.2%	-	-
Enterprise Value (EV) ¹	709.3	414	1,304	3,918	4,270	4,545	4,451	4,472
Change	-	-41.63%	215.07%	200.38%	8.97%	6.45%	-2.07%	0.46%
P/E	-6.92x	-4x	-9.45x	-17.5x	-13.4x	-12.2x	-15.4x	-30.5x
PBR	5.3x	2.07x	6.96x	11x	20.6x	18.3x	16.1x	17.1x
PEG	-	0.1x	0.8x	-0.7x	-0.4x	53.8x	0.7x	0.6x
Capitalization / Revenue	46.3x	14.1x	-	-	-	856x	34.2x	12.3x
EV / Revenue	37.7x	12.5x	-	-	-	801x	31.3x	11.4x
EV / EBITDA	-5.57x	-	-	-	-11.1x	-10.6x	-14.4x	-38.9x
EV / EBIT	-5.46x	-3.08x	-7.62x	-15.5x	-11.1x	-10.4x	-12.9x	-27.8x
EV / FCF	-5.37x	-3.1x	-8.98x	-19.5x	-14.2x	-16.4x	-20.3x	-53x
FCF Yield	-18.6%	-32.3%	-11.1%	-5.13%	-7.04%	-6.09%	-4.93%	-1.89%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-3.59	-2.26	-1.99	-2.47	-3.29	-3.283	-2.584	-1.308
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	18.82	33.19	-	-	-	5.677	142.2	393.7
EBITDA ¹	-127.3	-	-	-	-383	-429.2	-308.8	-114.9
EBIT ¹	-129.9	-134.4	-171.3	-252.1	-384.6	-437.1	-345.3	-160.8
Net income ¹	-131.8	-134.5	-165.8	-246.3	-377.9	-429.8	-359.7	-178.7
Net Debt ¹	-162.8	-53.53	-51.84	-127.7	-223.8	-316.5	-410.4	-390
Reference price ²	24.84	9.05	18.80	43.22	44.05	39.90	39.90	39.90
Nbr of stocks (in thousands)	35,108	51,663	72,143	93,615	102,007	121,785	-	-
Announcement Date	7/3/22	7/3/23	19/3/24	27/2/25	3/3/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SCHOLAR ROCK HOLDING CORPORATION	-12.38x	816.02x	-10.8x	-.--%	4.95B
WUXI APPTEC CO., LTD.	20.07x	7.14x	14.31x	1.48%	68.98B
ARGENX SE	28.61x	7.85x	24.63x	0.05%	53.15B
LONZA GROUP AG	35.29x	6.26x	18.73x	0.92%	50.83B
IQVIA HOLDINGS INC.	34.21x	3.36x	14.49x	-.--%	44.61B
REVOLUTION MEDICINES, INC.	-19.62x	197.94x	-20.83x	-.--%	40.57B
BEONE MEDICINES AG	49.56x	5.68x	31.19x	-.--%	42.53B
CELLTRION, INC.	27.19x	7.72x	19.99x	0.39%	30.95B
WUXI BIOLOGICS (CAYMAN) INC.	29.37x	6.23x	16.17x	-.--%	25.44B
BIONTECH SE	-13.66x	5.14x	-6.23x	-.--%	22.66B
Average	17.86x	106.33x	10.17x	0.28%	38.47B
Weighted average by Cap.	22.76x	36.92x	13.55x	0.42%